Showing results (331-340 of 333) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 333 results.
The Lancet. Oncology|August 1, 2024
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trialYi-Long Wu, Valentina Guarneri, Pei Jye Voon, et al.
The New England Journal of Medicine|September 9, 2025
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLCJames Chih-Hsin Yang, Shun Lu, Hidetoshi Hayashi, et al.
The New England Journal of Medicine|June 26, 2024
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLCByoung C Cho, Shun Lu, Enriqueta Felip, et al.
Pageof 34